Expertise in
3
conditions

Ida Colantonio

Cuneo, IT 
Expertise in
3
conditions
Cuneo, IT 

Overview

Ida Colantonio practices practicing medicine in Cuneo, Italy.

Ms. Colantonio is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).

She is actively involved in clinical research, co-authoring 22 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Cuneo, Italy
Other Locations
Santa Croce, Italy
Piemonte, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase II, Open-label Study of Atezolizumab in a Cohort of Pretreated, Advanced Non-small Cell Lung Cancer (NSCLC) Patients With Rare Histological Subtypes (CHANCE Trial).
Phase II, Open-label Study of Atezolizumab in a Cohort of Pretreated, Advanced Non-small Cell Lung Cancer (NSCLC) Patients With Rare Histological Subtypes (CHANCE Trial).
Enrollment Status: Completed
Publish Date: March 01, 2024
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
REACTION: A Phase II Study of Etoposide and Cis/Carboplatin With or Without Pembrolizumab in Untreated Extensive Small Cell Lung Cancer
REACTION: A Phase II Study of Etoposide and Cis/Carboplatin With or Without Pembrolizumab in Untreated Extensive Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug
Study Drugs: Pembrolizumab, Cis/carboplatin, Etoposide
Study Phase: Phase 2
An Open-label, Randomized Phase III Study of Early Switch Maintenance vs DElayed Second-line Nivolumab in Advanced Stage Squamous Non Small-cell Lung Cancer (NSCLC) Patients After Standard First-line Platinum-based Chemotherapy - EDEN Trial
An Open-label, Randomized Phase III Study of Early Switch Maintenance vs DElayed Second-line Nivolumab in Advanced Stage Squamous Non Small-cell Lung Cancer (NSCLC) Patients After Standard First-line Platinum-based Chemotherapy - EDEN Trial
Enrollment Status: Unknown
Publish Date: October 03, 2022
Intervention Type: Other, Drug
Study Drug: Nivolumab
Study Phase: Phase 3
View 2 Less Clinical Trials

22 Total Publications

Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation.
Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation.
Journal: Tumori
Published: October 18, 2025

Frequently Asked Questions about Ida Colantonio

Is Ida Colantonio a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Ida Colantonio is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ida Colantonio participate in research or clinical trials?

Yes. Ida Colantonio has published 22 articles and abstracts on conditions like Lung Cancer. You can view a list of Ida Colantonio's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Colantonio's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile